Baysient LLC

There is no one right dose for all patients. That is why we develop Compuceutical drug therapies, improving outcomes with tailored treatments.

[Baysient LLC @baysient]

Up to 50% of adalimumab patients experience secondary loss of response. For many, it's pharmacokinetic: drug clearance varies, exposure drops, antibodies form.

iDose estimates individual clearance and personalizes dosing to reduce treatment failure.

https://t.co/zinm26oZM3

[Baysient LLC @baysient]

iDose = decision support software for rheumatologists.

It calculates personalized biologic doses for RA patients based on their individual drug clearance, so doctors can optimize treatment instead of using standard dosing for everyone.

https://t.co/DwgCzcBJyb

[Baysient LLC @baysient]

Managing biologic therapy for inflammatory diseases? iDose GEN7.0 provides PK-informed dosing support for 17 indications.

Learn more: https://t.co/DwgCzcBJyb

[Baysient LLC @baysient]

May is #NationalNursesMonth

To the nurses managing infusions, coordinating care, catching complications, and advocating for patients:

Your clinical expertise and dedication make healthcare work.

Thank you.

[Baysient LLC @baysient]

Happy National Doctors' Day to the physicians dedicated to advancing patient care. Your expertise, commitment, and compassion make a difference every day. Thank you.

[Baysient LLC @baysient]

IBD treatment paradigm shift:
❌ Reactive: Standard dose → wait for failure → adjust
�� Proactive: Measure clearance → personalize immediately → prevent failure
https://t.co/Qwi86OSieg

[Baysient LLC @baysient]

Celebrating GI Nurses & Associates Week! To all the GI nurses and associates managing infusions, monitoring treatments, and supporting patients: thank you. #GINursesWeek

[Baysient LLC @baysient]

March is Colorectal Cancer Awareness Month. Therapeutic drug monitoring of monoclonal antibodies with TuMinimize helps oncology providers optimize treatment for each patient's individual characteristics. https://t.co/gOtT1G3ka6

[Baysient LLC @baysient]

How can individual PK monitoring help us track and slow disease progression in pediatric IBD? Baysient's @DRMOULD explores this in her NICHD Pediatric Clinical Pharmacology lecture. Now available to watch: https://t.co/zP9tu6wYnX

[Baysient LLC @baysient]

Now available: Baysient's @drmould, presented in the NICHD's 2025–26 Pediatric Clinical Pharmacology Series covering PK-guided dosing, disease progression, and Bayesian adaptive dosing in pediatric IBD. https://t.co/zP9tu6wYnX

[Baysient LLC @baysient]

Our Founder & Chief Science Officer, @DRMOULD, will be speaking in the 2025-26 Pediatric Clinical Pharmacology Lecture Series hosted by the NICHD Clinical Pharmacology Training Network.

Register now: https://t.co/QTswhI3Maf

[Baysient LLC @baysient]

NEWS: Baysient launches iDose GEN7.0, expanding precision dosing platform to 16 inflammatory disease indications across gastroenterology, rheumatology, dermatology & pulmonology.
Read the press release: https://t.co/isBPoGyPxp

[Baysient LLC @baysient]

2026 is here. The data is clear. The tools are ready. Here's to a year where precision dosing becomes the standard, not the exception. Happy New Year from Baysient.

[Baysient LLC @baysient]

This holiday season, we celebrate the physicians and researchers advancing care for patients with inflammatory diseases. Wishing everyone a peaceful holiday.

[Baysient LLC @baysient]

Half of IBD patients lose biologic response within a year. A review shows how proactive TDM with iDose prevents that.
https://t.co/YHKOoluDNZ

[Baysient LLC @baysient]

This Thanksgiving, we're grateful for the gastroenterologists, researchers, and healthcare teams advancing care for IBD patients. Your dedication makes a difference. Wishing everyone a peaceful holiday.

[Baysient LLC @baysient]

Up to 50% of IBD patients lose response to biologics within a year. A study shows how proactive therapeutic drug monitoring with tools like iDose can prevent that. Better durability, fewer failures, smarter dosing.

📖 https://t.co/YHKOoluDNZ

[Baysient LLC @baysient]

This National Family Caregivers Month, we honor those who manage complex care with quiet strength. Better patient outcomes mean lighter caregiver burdens, and that's work worth supporting. Thank you to every family caregiver.

[Baysient LLC @baysient]

Today, we honor the veterans who have served our country with courage, dedication, and sacrifice. Your service has protected our freedoms and shaped the world we live in.

To all veterans—thank you. Your commitment inspires us every day.

[Baysient LLC @baysient]

A Mumbai study shows how precision dosing transforms IBD care. With iDose, patients achieved remission, and one cut costs 60% while maintaining response. Right dose. Right time. Better outcomes.

📖 https://t.co/aTf1VzJPyJ